Moderna Inc

Moderna is an American pharmaceutical and biotechnology company with headquarters in Massachusetts. Moderna rose to prominence during the Covid-19 pandemic as a primary candidate for the development of a vaccine, which was then authorised for distribution to the public across multiple countries at the start of 2021. Moderna’s work focuses on drug discovery and development, with a heavy emphasis on artificial mRNA cells. Moderna stock is listed on the NASDAQ exchange and it is also a constituent of the NASDAQ 100 index, which is a modified measure of the top 100 non-financial companies in the US on the exchange. Spread bet or trade CFDs on our Moderna share price.